Research
Hormonal
Semaglutide is effective for weight loss in obese or overweight patients.
Semaglutide can be considered as a treatment option for weight management in obese or overweight patients.
StrongSupportsmedium confidence
meta-analyses of randomized controlled trials (RCTs) of semaglutide in patients with T2DM have shown benefits of the drug on glycaemic control and weight loss.
Why this rating
Based on meta-analysis of randomized controlled trials.
Source
Once‐weekly semaglutide for obesity or overweight: A systematic review and meta‐analysis
Ke He et al. · Diabetes Obesity and Metabolism · 2021
Meta-analysisCited 12×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →